The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
about
C-Peptide: the missing link in diabetic nephropathy?Physiological effects and therapeutic potential of proinsulin C-peptideAn In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to ErythrocytesAcute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus.Association between erythrocyte Na+K+-ATPase activity and some blood lipids in type 1 diabetic patients from Lagos, NigeriaC-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.Mass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants.Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus.A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.Role of C-peptide in human physiology.C-peptide: new findings and therapeutic implications in diabetes.Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.C-peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans.The clinical potential of C-peptide replacement in type 1 diabetes.Specific binding of proinsulin C-peptide to human cell membranes.The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.Role of C-Peptide in the regulation of microvascular blood flow.Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes.C-peptide and long-term complications of diabetes.Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.Computational Biomechanics of Human Red Blood Cells in Hematological Disorders.Molecular effects of C-Peptide in microvascular blood flow regulation.Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production.C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus.C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.Effect of yeast biomass with high content of carotenoids on erythrocyte deformability, NO production and Na,K-ATPase activity in healthy and LPS treated rats.Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties.Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin.
P2860
Q24643550-CF5EBACD-2983-4973-8369-D8254E41F046Q27012286-0727F043-DD10-4E72-A22B-2665E7340F7CQ29400681-07FD2D01-5B61-4BC0-B3B2-A4B0B5759561Q33201760-26513D6F-73C0-4041-8E29-E697B7AA8C42Q33301066-34BBD68F-5485-49A2-BD10-296176F847C5Q33335159-3A1A94AD-281A-4803-BBD2-F18B370F40FEQ33526376-E0E5505C-419C-4ABE-8D7C-34C507DEC6B0Q33590082-AAA34609-580E-4C22-B1DA-56B08F0AD468Q33682566-8B8914CD-7F67-4F51-AA5B-8349779A72B1Q33898773-8F3385D5-6BD7-4DA9-8E46-D4A8EDD1147CQ33979590-B71E38DB-13E3-442A-81CA-C45E210C3E09Q34658875-5D7D4490-D21E-4B42-9B36-581A793F39D7Q35825308-BE2D1851-86CA-4140-B150-51E173E2E9BAQ35857755-D036BC98-24A6-43DA-8D9A-D75D260F6B3DQ36671827-6E65F35A-CE62-46EB-8618-E2E176A6C47EQ37147785-E741F861-08C8-4EB1-AB44-6653DBB0D6B0Q37231760-06456164-A524-476E-AFE2-0C74F1BD52F5Q37426635-7B11319D-C658-4823-ADEC-794A00A8CAC9Q37428866-5D311C76-B17D-49B8-8340-1095B8C32009Q37464358-CF98AC83-45B9-4C26-B003-A821628A9089Q37815562-EF1BF54C-AFB3-4C14-9E31-F9E349CB4C89Q38356851-92053B17-F72F-4034-B57A-78FA054116C9Q38998761-07A45599-C3B8-4EA0-97D4-1D27536F0CF6Q39224550-4B671A80-3592-4651-9336-08F027DC2322Q40506406-8A2E891D-5EAA-4357-BF53-E8BD77F449F6Q42493935-8375ACC0-0059-4416-B785-A6EFD21764FAQ43078102-18205A12-F6D8-4121-BE1C-EE4ADA40A6A3Q43687338-B1DE2D01-2F52-4BB2-A3B4-F2907DFD2D32Q44473621-58F03992-DF4B-4986-AED2-8B43A9473952Q46575822-660C78B7-2C03-49C1-87D8-F200ED5898EEQ48238409-8D014496-80EC-495E-BADB-5CA42D94BC86Q48327851-1A3D259E-BEAE-4116-AC84-6E799FE3AE4CQ50463857-F41E3FAC-B8A3-4156-94BF-08768297AEE6
P2860
The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The effect of human proinsulin ...... with Type I diabetes mellitus.
@ast
The effect of human proinsulin ...... with Type I diabetes mellitus.
@en
type
label
The effect of human proinsulin ...... with Type I diabetes mellitus.
@ast
The effect of human proinsulin ...... with Type I diabetes mellitus.
@en
prefLabel
The effect of human proinsulin ...... with Type I diabetes mellitus.
@ast
The effect of human proinsulin ...... with Type I diabetes mellitus.
@en
P2093
P356
P1433
P1476
The effect of human proinsulin ...... with Type I diabetes mellitus.
@en
P2093
Engelbach M
Pfützner A
Schneider S
P2888
P304
P356
10.1007/S001250051180
P577
1999-04-01T00:00:00Z
P5875
P6179
1037638749